Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-10

Clinical Trial Update: Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the combination of insulin detemir and sitagliptin for blood glucose control in adults with Type 2 diabetes; results were posted after …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Januvia (sitagliptin)
  • Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2010-12-10